Protagonist Therapeutics chief medical officer sells shares for tax obligations
Officer of Protagonist Therapeutics, Inc. (NASDAQ:PTGX), a $2.2 billion market cap biotech company, recently reported the sale of 3,640 shares of common stock on January 16, 2025. The transactions ...
Onto innovation's SVP Srinivas sells shares worth $169,535
Vedula Srinivas, the Senior Vice President of Customer Success at Onto Innovation Inc. (NYSE:ONTO), recently sold a portion of his holdings in the company. According to a recent SEC filing, Srinivas ...
If You Invested $10,000 In CTO Realty Growth Stock 10 Years Ago, How Much Would You Have Now?
CTO Realty Growth, Inc. (NYSE:CTO) is a publicly traded real estate investment trust that owns and operates a portfolio of ...
EverQuote (NASDAQ:EVER) Price Target Lowered to $25.00 at JPMorgan Chase & Co.
EverQuote (NASDAQ:EVER – Free Report) had its price target trimmed by JPMorgan Chase & Co. from $28.00 to $25.00 in a ...